Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveResults from FRONT study: A multicenter, randomized, open-label clinical trial of fruquintinib as maintenance therapy after 1L treatment in metastatic colorectal cancer (mCRC)
Xu, X.; Yu, Y.; Liu, Q.; Wang, Y.; Cui, Y.; Li, W.; Li, Q.; Feng, Y.; Liang, L.; Yu, S.; Lv, Z.; Liu, T.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save